Related Experiment Video
Updated: May 22, 2026
09:35
Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection
Published on: February 2, 2018
Polypropylenimine generation four: a suitable vector for targeted gene alteration in vitro
Juergen Klingler1, Dieter Kaufmann
1Institute of Human Genetics, University of Ulm, Albert-Einstein-Allee, Ulm, Germany.
Journal of Drug Targeting
|May 15, 2012
Summary
Generation four polypropylenimine dendrimers effectively deliver modified oligonucleotides for targeted gene alteration. This DNA delivery method shows high cellular uptake and corrects specific gene mutations with low toxicity.
Area of Science:
- Biotechnology
- Molecular Biology
- Gene Therapy
Background:
- Polypropylenimine dendrimers are recognized as potential vectors for DNA delivery.
- Previous research has not explored their use for delivering modified oligonucleotides in targeted gene alteration.
Purpose of the Study:
- To investigate the efficacy of generation four polypropylenimine dendrimers in delivering modified oligonucleotides.
- To assess their potential for targeted gene alteration via correction of a specific point mutation.
Main Methods:
- Utilized generation four polypropylenimine dendrimers to deliver a 45-base phosphorothioate-modified DNA oligonucleotide.
- Targeted the hypoxanthine-guanine phosphoribosyltransferase (hprt) gene in cultured V79 hamster fibroblasts and HuH-7 human liver cells.
- Employed fluorescence labeling, transmission electron microscopy, and immunolabeling to track oligonucleotide localization and assess cellular effects.
Main Results:
- Achieved high cellular uptake of labeled oligonucleotides in both cell lines with minimal toxicity.
- Confirmed predominant nuclear localization of oligonucleotides 24 hours post-transfection.
- Demonstrated successful correction of the hprt point mutation in V79-400 cells, indicating biological activity.
Conclusions:
- Generation four polypropylenimine dendrimers are suitable vectors for transfecting modified oligonucleotides.
- This approach facilitates targeted gene alteration by correcting specific point mutations.
